Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Current Opinion in Oncology|March 26, 2023
Window-of-opportunity clinical trials for biomarker discovery in head and neck squamous cell carcinomaGrégoire Marret, Edith Borcoman, Christophe Le TourneauCancer Cell|March 14, 2025
Turning the kaleidoscope: Innovations shaping the future of clinical trial designGrégoire Marret, Mercedes Herrera, Lillian L SiuLa Revue Du Praticien|June 23, 2021
["Immunotherapy in head and neck squamous cell carcinoma"]Grégoire Marret, Édith Borcoman, Christophe Le TourneauExpert Opinion on Biological Therapy|July 20, 2019
Pembrolizumab for the treatment of cervical cancerGrégoire Marret, Edith Borcoman, Christophe Le TourneauBulletin Du Cancer|February 29, 2016
[Medical management of cholangiocarcinomas in 2015]Grégoire Marret, Cindy Neuzillet, Benoît Rousseau, et al.Cancer Treatment and Research Communications|October 23, 2018
Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patientsGrégoire Marret, Ludovic Doucet, Christophe Hennequin, et al.Cancers|January 11, 2022
HDAC Inhibition to Prime Immune Checkpoint InhibitorsEdith Borcoman, Maud Kamal, Grégoire Marret, et al.Head & Neck|February 2, 2019
Ten-year outcome of curative "exclusive" chemotherapy in N0M0 squamous cell carcinoma of the larynx and pharynx with complete clinical responseOllivier Laccourreye, Grégoire Marret, François Rubin, et al.European Journal of Cancer (Oxford, England : 1990)|March 11, 2020
Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcomeEmeline Colomba, Grégoire Marret, Giulia Baciarello, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 16, 2025
Palliative care outpatient interventions to limit aggressive care at end-of-life for patients with advanced soft tissue sarcomasLaura Thery, Thomas Zurecki, Carole Bouleuc, et al.Pageof 3